Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer

The TEM8 protein coded by the ANTXR1 gene represents an emerging biomarker in solid tumors. In addition to the various roles TEM8 plays in oncogenesis, including angiogenesis, epithelial-to-mesenchymal transition, and cell migration, it has also been shown that the overexpression of the ANTXR1 gene...

Full description

Saved in:
Bibliographic Details
Main Authors: L. S. Franco, S. Arunachalam, A. Chauhan, S. A. Kareff, P. L. Hallenbeck
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2024.1520223/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591023194243072
author L. S. Franco
S. Arunachalam
A. Chauhan
S. A. Kareff
P. L. Hallenbeck
author_facet L. S. Franco
S. Arunachalam
A. Chauhan
S. A. Kareff
P. L. Hallenbeck
author_sort L. S. Franco
collection DOAJ
description The TEM8 protein coded by the ANTXR1 gene represents an emerging biomarker in solid tumors. In addition to the various roles TEM8 plays in oncogenesis, including angiogenesis, epithelial-to-mesenchymal transition, and cell migration, it has also been shown that the overexpression of the ANTXR1 gene in solid tumors correlates with poor prognostic indicators in several solid tumor histologies. As such, TEM8 has been identified as the target of novel oncologic therapies. It is especially attractive given its selective expression on the surface of solid tumor cells and associated stromal cells, such as cancer stem cells, invasive cancer cells, and immune cells, such as macrophages, angiogenic endothelial cells, pericytes, and cancer-associated fibroblasts. Furthermore, TEM8 plays this unique role as a mostly non-mutated gene in solid cancers. Here, we demonstrate that elevated expression of ANTXR1 in bladder cancer showed a statistical difference not only in overall survival (OS) but in progression-free survival (PFS), confirming the prognostic biomarker power of ANTXR1 expression.
format Article
id doaj-art-46686fb5348844bb9a26c379796d7a71
institution Kabale University
issn 2296-889X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj-art-46686fb5348844bb9a26c379796d7a712025-01-23T05:10:30ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2025-01-011110.3389/fmolb.2024.15202231520223Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancerL. S. Franco0S. Arunachalam1A. Chauhan2S. A. Kareff3P. L. Hallenbeck4Seneca Therapeutics, Inc., Blue Bell, PA, United StatesSeneca Therapeutics, Inc., Blue Bell, PA, United StatesSylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, United StatesLynn Cancer Institute, Boca Raton Regional Hospital, Boca Raton, FL, United StatesSeneca Therapeutics, Inc., Blue Bell, PA, United StatesThe TEM8 protein coded by the ANTXR1 gene represents an emerging biomarker in solid tumors. In addition to the various roles TEM8 plays in oncogenesis, including angiogenesis, epithelial-to-mesenchymal transition, and cell migration, it has also been shown that the overexpression of the ANTXR1 gene in solid tumors correlates with poor prognostic indicators in several solid tumor histologies. As such, TEM8 has been identified as the target of novel oncologic therapies. It is especially attractive given its selective expression on the surface of solid tumor cells and associated stromal cells, such as cancer stem cells, invasive cancer cells, and immune cells, such as macrophages, angiogenic endothelial cells, pericytes, and cancer-associated fibroblasts. Furthermore, TEM8 plays this unique role as a mostly non-mutated gene in solid cancers. Here, we demonstrate that elevated expression of ANTXR1 in bladder cancer showed a statistical difference not only in overall survival (OS) but in progression-free survival (PFS), confirming the prognostic biomarker power of ANTXR1 expression.https://www.frontiersin.org/articles/10.3389/fmolb.2024.1520223/fullTEM8prognostic biomarkerbladder cancerdownstream pathwaysurvival
spellingShingle L. S. Franco
S. Arunachalam
A. Chauhan
S. A. Kareff
P. L. Hallenbeck
Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
Frontiers in Molecular Biosciences
TEM8
prognostic biomarker
bladder cancer
downstream pathway
survival
title Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
title_full Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
title_fullStr Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
title_full_unstemmed Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
title_short Elevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
title_sort elevated expression of antxr1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer
topic TEM8
prognostic biomarker
bladder cancer
downstream pathway
survival
url https://www.frontiersin.org/articles/10.3389/fmolb.2024.1520223/full
work_keys_str_mv AT lsfranco elevatedexpressionofantxr1geneintumorsisapoorprognosticbiomarkerforpatientswithbladdercancer
AT sarunachalam elevatedexpressionofantxr1geneintumorsisapoorprognosticbiomarkerforpatientswithbladdercancer
AT achauhan elevatedexpressionofantxr1geneintumorsisapoorprognosticbiomarkerforpatientswithbladdercancer
AT sakareff elevatedexpressionofantxr1geneintumorsisapoorprognosticbiomarkerforpatientswithbladdercancer
AT plhallenbeck elevatedexpressionofantxr1geneintumorsisapoorprognosticbiomarkerforpatientswithbladdercancer